Fetal alcohol spectrum disorders (FASD) are the range of conditions that can be caused by prenatal alcohol exposure. Current estimates put the prevalence of FASD in the UK at around 3%, making it the most common neurodevelopmental disorder in the country; yet knowledge, understanding and services are severely lacking.
This presentation covered the cultural context of alcohol use in pregnancy in Scotland, the variety of effects that FASD can have for individuals and the implications of FASD in an everyday context, as well as the difficulties of making a diagnosis and the absence of adult pathways for this diagnosis.
Dr Shields and Dr Brown both stressed the importance of raising awareness about FASD as a preventative measure.
The EUFASD conference will take place from 14th to 16th September 2020.
The first Regional Competence Center for children with prenatal alcohol/drug exposure in the Nordic countries is proud to host this exciting cutting-edge conference for the first time in Norway.
The UK has one of the highest estimated rates of Foetal Alcohol Spectrum Disorders (FASD) in the world, but these conditions are commonly misunderstood, under-recognised and under-diagnosed.
9th International Research Conference on Adolescents and Adults with Fetal Alcohol Spectrum Disorders
Although there have been thousands of published articles on FASD, there still remains limited research specifically on adolescents and adults with FASD. As individuals diagnosed with FASD continue to age, the “need to know” across a broad spectrum of areas continues to be critically important for identifying clinically relevant research questions and directions.
Objectives: To estimate the prevalence of fetal alcohol spectrum disorder (FASD) among young people in youth detention in Australia. Neurodevelopmental impairments due to FASD can predispose young people to engagement with the law. Canadian studies identified FASD in 11%–23% of young people in corrective services, but there are no data for Australia.
To estimate the economic burden and cost attributable to Fetal Alcohol Spectrum Disorder (FASD) in Canada in 2013.
Hippocampus-Dependent Memory and Allele-Specific Gene Expression in Adult Offspring of Alcohol-Consuming Dams after Neonatal Treatment with Thyroxin or Metformin
Fetal alcohol spectrum disorder (FASD), the result of fetal alcohol exposure (FAE), affects 2–11% of children worldwide, with no effective treatments. Hippocampus-based learning and memory deficits are key symptoms of FASD. Our previous studies show hypothyroxinemia and hyperglycemia of the alcohol-consuming pregnant rat, which likely affects fetal neurodevelopment.